REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
67,90 R$
0,00%
(0,00) 1D
15 հոկ, 16:56:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN34...
Open
65,71 R$
High
67,90 R$
Low
65,71 R$
Mkt. cap
81,99 մլրդ
Avg. vol.
712,00
Volume
1,60 հզր
52-wk high
73,13 R$
52-wk low
49,91 R$
Shares outstanding
101,14 մլն
No. of employees
15 հզր
Open
65,71 R$
High
67,90 R$
Low
65,71 R$
Mkt. cap
81,99 մլրդ
Avg. vol.
712,00
Volume
1,60 հզր
52-wk high
73,13 R$
52-wk low
49,91 R$
Shares outstanding
101,14 մլն
No. of employees
15 հզր
News stories
From web sources and news partners
Yahoo Finance
·
6 ժամ առաջ
Regeneron Pharmaceuticals (REGN) Reports 84 Week Phase III Efficacy For FOP Treatment
Kalkine Media
·
7 ժամ առաջ
Regeneron's Andrew Murphy Executes Stock Option and Sells Shares Under 10b5-1 Plan on October 14
MarketBeat
·
8 ժամ առաջ
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock: Insider Andrew Murphy Sells 4,147 Shares
www.marketscreener.com
·
9 ժամ առաջ
Regeneron Pharmaceuticals Insider Sold Shares Worth $3,204,376, According to a Recent SEC Filing
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc BDR
CEOLeonard Schleifer
Employees15,3 հզր
Founded1988
HeadquartersԹառիթաուն, Նյու Յորք, Միացյալ Նահանգներ
Sector-
Websiteregeneron.com